Molecular characterization of oxacillinases and genotyping of invasive Acinetobacter baumannii isolates using repetitive extragenic palindromic sequence-based polymerase chain reaction in Ankara between 2004 and 2010

Scandinavian Journal of Infectious Diseases

Volumn 45, Issue 1, 2013, Pages 26-31

  Ergin, Alper ^a   Hascelik, Gülsen ^a   Eser, Ozgen Koseoglu ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acinetobacter baumannii; OXA; Rep PCR

Indexed keywords

AMIKACIN; BACTERIAL ENZYME; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; DORIPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; OXACILLINASE; PIPERACILLIN; TIGECYCLINE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; FEMALE; GENOTYPE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; POLYMERASE CHAIN REACTION; REPETITIVE EXTRAGENIC PALINDROMIC SEQUENCE BASED POLYMERASE CHAIN REACTION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; FEMALE; GENOTYPING TECHNIQUES; HUMANS; INVERTED REPEAT SEQUENCES; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; TURKEY;

EID: 84871364219     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2012.708782     Document Type: Article

References (21)

1. Carvalho K R, C arvalho-Assef AP, P eirano G, G alvao dos Santos LC, Pereira MJ, Asensi MD . Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying bla OXA-23 collected from hospitals in Rio de Janeiro, Brazil . Int J Antimicrob Agents 2009; 34 : 25- 8 .
2. Lee K, Y ong D, J eong S H, C hong Y. M ultidrug-resistant Acinetobacter spp .: increasingly problematic nosocomial pathogens. Yonsei Med J 2011; 52 : 879- 91 .
3. Kempf M, Rolain J . Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options . Int J Antimicrob Agents 2012; 39 : 105- 14 .
4. Walther-Rasmussen J, H oiby N. O XA-type carbapenemases. J Antimicrob Chemother 2006; 57 : 373- 83 .
5. Runnegar N, S idjabat H, S haron Goh H M, N immo G R, Schembri MA, Paterson DL . Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period . J Clin Microbiol 2010; 48 : 4051- 6 .
6. Yan Z, S hen D, C ao J, C hen R, W ei X, L iu L, et a l . Susceptibility patterns and molecular epidemiology of multidrug-resistant Acinetobacter baumannii strains from three military hospitals in China . Int J Antimicrob Agents 2010; 35 : 269- 73 .
7. Clinical and Laboratory Standards Institute (CLSI). P erformance standards for antimicrobial susceptibility testing . Nineteenth informational supplement. M100-S19 . Wayne, PA: CLSI ; 2009 .
8. Woodford N, E llington M J, C oelho J M, T urton J F, W ard M E, Brown S, et al . Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp . Int J Antimicrob Agents 2006; 27 : 351- 3 .
9. Qi C, Malczynski M, Parker M, Scheetz M H . Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007 . J Clin Microbiol 2008; 46 : 1106- 9 . (Pubitemid 351380009)
10. Owen R J, L i J, N ation R L, S pelman D. I n vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates . J Antimicrob Chemother 2007; 59 : 473- 7 . (Pubitemid 47073453)
11. Pillar C M, T orres M K, B rown N P, S hah D, S ham D F . In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by Gram-negative bacteria, against recent clinical isolates from the United States . Antimicrob Agents Chemother 2008; 52 : 4388- 99 .
12. Mugnier PD, P oirel L, N aas T, N ordmann P. W orldwide dissemination of the bla OXA-23 carbapenemase gene of Acinetobacter baumannii . Emerg Infect Dis 2010; 16 : 35- 40
13. Kim C, Lee Y L ee H, W oo G, S ong W, K im M, et al . Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182 . Diagn Microbiol Infect Dis 2010; 68 : 432- 8 .
14. Mendes R E, B ell J M, T urnidge J D, C astanheira M, Jones RN . Emergence and widespread dissemination of OXA-23, - 24/40 and - 58 carbapenemases among Acinetobacter spp. in Asia-Pacifi c nations: report from the SENTRY surveillance program . J Antimicrob Chemother 2009; 63 : 55- 9 .
15. D 'A rezzo S, P rincipe L, C apone A, P etrosillo N, P etrucca A, Visca P . Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy . J Antimicrob Chemother 2011; 66 : 54- 61 .
16. Gur D, K orten V, U nal S, L alitagauri MD, C astanheira M . Increasing carbapenem resistance due to clonal dissemination of oxacillinase (OXA-23 and OXA-58)-producing Acinetobacter baumannii: report from the Turkish SENTRY program sites . J Med Microbiol 2008; 57 : 1529- 32 .
17. Carretto E, B arbarini D, F arina C, G rosini A, N icoletti P, Manso E . Use of the DiversiLab semiautomated repetitivesequence-based polymerase chain reaction for epidemiologic analysis on Acinetobacter baumannii isolates in different Italian hospitals . Diagn Microbiol Infect Dis 2008; 60 : 1- 7 . (Pubitemid 350235158)
18. Grisold A J, Z arfel G, S trenger V, F eierl G, L eirner E, M asoud L, et al . Use of automated repetitive-sequence based PCR for rapid laboratory confi rmation of nosocomial outbreaks . J Infect 2010; 60 : 44- 51 .
19. Fontana C, F avaro M, M inelli S, B ossa M C, T estore GP, Leonardis F, et al . Acinetobacter baumannii in intensive care unit: a novel system to study clonal relationship among the isolates . BMC Infect Dis 2008; 8 : 79- 88 .
20. B aang J H, A xelrod P, D ecker B K, H ujer AM, D ash G, Truant AR, et al . Longitudinal epidemiology of multidrugresistant (MDR) Acinetobacter species in a tertiary care hospital . Am J Infect Control 2012 ; 40 : 134- 7 .
21. Gordon NC, W areham DW. M ultidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance . Int J Antimicrob Agents 2010; 35 : 219- 26 .